Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort studyResearch in context panel

• Main Authors: Quentin M. Anstee (Author), Tina L. Berentzen (Author), Louise M. Nitze (Author), Maximilian Jara (Author), Anders B. Jensen (Author), Mette S. Kjær (Author), Kamal K. Mangla (Author), Jens M. Tarp (Author), Kamlesh Khunti (Author)
• Format: Book
• Published: Elsevier, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: The Fibrosis-4 Index (FIB-4) is used as a non-invasive tool for the presence of advanced liver fibrosis in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes. However, evidence for an association between FIB-4 and risk of mortality and/or liver-related...